Secondary Logo

Journal Logo

You can read the full text of this article if you:

Ovid Member Institutional Access
Original Contributions

Cannabinoid Receptor 1 Blocker Rimonabant (SR 141716) for Treatment of Alcohol Dependence

Results From a Placebo-Controlled, Double-Blind Trial

Soyka, Michael MD*†; Koller, Gabriele MD*; Schmidt, Peggy PhD*; Lesch, Otto-Michael MD; Leweke, Markus MD§; Fehr, Christoph MD; Gann, Horst MD; Mann, Karl F. MD# The investigators involved in the ACTOL Study

Author Information
Journal of Clinical Psychopharmacology: June 2008 - Volume 28 - Issue 3 - p 317-324
doi: 10.1097/JCP.0b013e318172b8bc
  • Buy

Abstract

© 2008 Lippincott Williams & Wilkins, Inc.